Effects of Alendronate and Alfacalcidol on the Femoral Bone Mass and Bone Strength in Orchidectomized Rats

Jun Iwamoto；Hideo Matsumoto；Tsuyoshi Takeda；Yoshihiro Sato；Edward Xu；James K. Yeh

orchidectomy ； BMD ； alendronate ； alfacalcidol ； rat

The Chinese Journal of Physiology

51卷6期（2008 / 12 / 01）

331 - 337

英文

The purpose of the present study was to compare the effects of alendronate (ALN) and alfacalcidol (ALF) on the femoral bone mass and bone strength in orchidectomized rats and to clarify the skeletal benefits of combined administration of ALN and ALF. Fifty male Sprague-Dawley rats, 3 months of age, were randomized by the stratified weight method into five groups: the age-matched control (CON), orchidectomy (ORX), ORX + ALN (2.5 μg/kg, s.c., 5 times a week), ORX + ALF (0.1 μg/kg, p. o., 5 times a week), and ORX + ALN + ALF groups. After 12 weeks of feeding, the femoral distal metaphysis and mid-diaphysis were processed for peripheral quantitative tomographic analysis and biomechanical testing. In the femoral distal metaphysis, ALN prevented the ORX-induced reduction in the trabecular volumetric bone mineral density (vBMD) and breaking energy, and ALF prevented the ORX-induced reduction in the trabecular vBMD and increased the breaking energy to values above those observed in the CON group. Both ALN and ALF increased the maximum load to values above those observed in the ORX group. The improvements in parameters described above were more pronounced when ALN and ALF were administered in combination. In the femoral mid-diaphysis, on the other hand, ALN did not significantly affect the cortical bone parameters, whereas ALF increased the cortical area and maximum load to values above those observed in the ORX group. Furthermore, no apparent benefit of combined administration of ALN and ALF was observed. These findings suggest differential effects of ALN and ALF on femoral bone mass and the beneficial effects of combined administration of ALN and ALF on the trabecular bone of the femur in ORX rats.

1. Behre, H.M.,Kliesch, S.,Leifke, E.,Link, T.M.,Nieschlag, E.(1997).Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.J. Clin. Endocrinol. Metab.,82,2386-2390.
2. Bertelloni, S.,Baroncelli, G.I.,Battini, R.,Perri, G.,Saggese, G.(1995).Short-term effect of testosterone treatment on reduced bone density in boys with constitutional delay of puberty.J. Bone Miner. Res.,10,1488-1495.
3. Broulik, P.D.,Rosenkrancova, J.,Ruzicka, P.,Sedlacek, R.(2005).Effect of alendronate administration on bone mineral density and bone strength in castrated rats.Horm. Metab. Res.,37,414-418.
4. Chappard, D.,Petitjean, M.,Alexandre, C.,Vico, L.,Minaire, P.,Riffat, G.(1991).Cortical osteoclasts are less sensitive to etidronate than trabecular osteoclasts.J. Bone Miner. Res.,6,673-680.
5. Erben, R.G.,Eberle, J.,Stahr, K.,Goldberg, M.(2000).Androgen deficiency induces high turnover osteopenia in aged male rats: a sequential histomorphometric study.J. Bone Miner. Res.,15,1085-1098.
6. Ferretti, J.L.,Capozza, R.F.,Zanchetta, J.R.(1996).Mechanical validation of a tomographic (pQCT) index for noninvasive estimation of rat femur bending strength.Bone,18,97-102.
7. Guo, C.Y.,Jones, T.H.,Eastell, R.(1997).Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover.J. Clin. Endocrinol. Metab.,82,658-665.
8. Huuskonen, J.,Arnala, I.,Olkkonen, H.,Alhava, E.(2001).Alendronate influences bending force of femoral diaphysis after orchidectomy in rats.Ann. Chir. Gynaecol.,90,109-114.
9. Ito, M.,Azuma, Y.,Takagi, H.,Komoriya, K.,Ohta, T.,Kawaguchi, H.(2002).Curative effect of combined treatment with alendronate and 1α-hydroxyvitamin D3 on bone loss by ovariectomy in aged rats.Jpn. J. Pharmacol.,9,255-266.
10. Iwamoto, J.,Seki, A.,Takeda, T.,Sato, Y.,Yamada, H.(2005).Effects of risedronate on femoral bone mineral density and bone strength in sciatic neurectomized young rats.J. Bone Miner. Metab.,23,456-462.
11. Iwamoto, J.,Seki, A.,Takeda, T.,Sato, Y.,Yamada, H.,Yeh, J.K.(2006).Effect of risedronate on the cortical and cancellous bone mass and mechanical properties in ovariectomized rats: A comparison with the effects of alfacalcidol.J. Nutr. Sci. Vitaminol.,52,393-401.
12. Iwamoto, J.,Seki, A.,Takeda, T.,Sato, Y.,Yamada, H.,Yeh, J.K.(2006).Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats.Exp. Anim.,55,357-367.
13. Iwamoto, J.,Seki, A.,Takeda, T.,Sato, Y.,Yamada, H.,Yeh, J.K.(2006).Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidol.Exp. Anim.,55,333-342.
14. Iwamoto, J.,Seki, A.,Takeda, T.,Sato, Y.,Yamada, H.,Yeh, J.K.(2006).Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic rats.J. Nutr. Sci. Vitaminol.,52,1-8.
15. Iwamoto, J.,Takeda, T.,Katsumata, T.,Tanaka, T.,Ichimura, S.,Toyama, Y.(2002).Effect of etidronate on bone in orchidectomized and sciatic neurectomized adult rats.Bone,30,360-367.
16. Iwamoto, J.,Yeh, J.K.,Takeda, T.(2003).Effect of vitamin K2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats.J. Bone Miner. Res.,18,776-783.
17. Kobayashi, M.,Hara, K.,Akiyama, Y.(2004).Effects of vitamin K2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet.Bone,35,1136-1143.
18. Lind, P.M.,Lind, L.,Larsson, S.,Orberg, J.(2001).Tortional testing and peripheral quantitative computed tomogrfaphy in rat humerus.Bone,29,265-270.
19. Prakasam, G.,Yeh, J.K.,Chen, M.M.,Castro-Magana, M.,Liang, C.T.,Aloia J.F.(1999).Effects of growth hormone and testosterone on cortical bone formation and bone density in aged orchidectomized rats.Bone,24,491-497.
20. Rogers, M.J.,Frith, J.C.,Luckman, S.P.,Coxon, F.R.,Benford, H.L.,Monkkonen, J.,Auriola, S.,Chilton, K.M.,Russell, R.G.G.(1999).Molecular mechanism of action of bisphosphonate.Bone,24,73-79.
21. Shiraishi, A.,Higashi, S.,Masaki, T.,Saito, M.,Ito, M.,Ikeda, S.,Nakamura, T.(2002).Comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis.Calcif. Tissue Int.,71,69-79.
22. Shiraishi, A.,Takeda, S.,Masaki, T.,Higuchi, Y.,Uchiyama, Y.,Kubodera, N.,Sato, K.,Ikeda, K.,Nakamura, T.,Matsumoto, T.,Ogata, E.(2000).Alfacalcidol inhibits bone resorption and stimulate formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen.J. Bone Miner. Res.,15,770-779.